Hypomelanotic Disorder
Symptoms, Doctors, Treatments, Advances & More

Hypomelanotic Disorder Overview

Save information for later
Sign Up

Learn About Hypomelanotic Disorder

What is the definition of Hypomelanotic Disorder?
Hypomelanotic disorder is a term that refers to types of skin conditions in which melanocytes (pigment cells) have a loss of pigment. Types of hypomelanotic disorders include vitiligo, ash leaf spots, and idiopathic guttate hypomelanosis, among others.
What are the symptoms of Hypomelanotic Disorder?
Symptoms of hypomelanotic disorders include loss of pigmentation that varies by the type of disorder. Symptoms of vitiligo include a complete loss of pigment in the skin that appears as well-delineated spots and patches. Symptoms of ash leaf spots include oval flattened areas of skin that lack pigment and angiofibromas on the face. Symptoms of idiopathic guttate hypomelanosis include small white flattened areas on sun-exposed skin areas.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hypomelanotic Disorder?
Treatment for hypomelanotic disorders depends on the type. Treatment for vitiligo may include corticosteroids, tacrolimus, pimecrolimus, ultraviolet B and PUVA therapy, self-tanning creams, and skin grafting. Treatment for ash leaf spots may include laser therapy. Treatment for idiopathis guttate hypomelanosis is not necessary.
Who are the top Hypomelanotic Disorder Local Doctors?
Elite in Hypomelanotic Disorder
Dr. Amit G. Pandya
Dermatology
Elite in Hypomelanotic Disorder
Dr. Amit G. Pandya
Dermatology
Referral required
Before you request

Sunnyvale Center (401)

401 Old San Francisco Road, Level 2, 
Sunnyvale, CA 
650-934-7676
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Amit Pandya is a Dermatologist practicing medicine in Sunnyvale, California. Dr. Pandya is rated as an Elite provider by MediFind in the treatment of Hypomelanotic Disorder. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Vitiligo, Hypomelanotic Disorder, Porphyria Cutanea Tarda, Melasma, and Thrombectomy. Dr. Pandya is board certified in Dermatology. Dr. Pandya is currently accepting new patients.

Elite in Hypomelanotic Disorder
Elite in Hypomelanotic Disorder
Referral may be required
Before you request

UPMC Shadyside Dermatology

580 South Aiken Avenue, Suites 200 & 201, 
Pittsburgh, PA 
412-681-1072
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Anuradha Bishnoi is a Dermatologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Bishnoi is rated as an Elite provider by MediFind in the treatment of Hypomelanotic Disorder. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Vitiligo, Hypomelanotic Disorder, Lichen Planus, and Melasma. Dr. Bishnoi is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Hypomelanotic Disorder
Dr. John E. Harris
Family Medicine
Elite in Hypomelanotic Disorder
Dr. John E. Harris
Family Medicine
Before you request

Office

7500 Dollarway Rd Ste 104, 
White Hall, AR 
870-247-7632
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Harris is a primary care provider, practicing in Family Medicine in White Hall, Arkansas. Dr. Harris is rated as an Elite provider by MediFind in the treatment of Hypomelanotic Disorder. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Hypomelanotic Disorder, Vitiligo, Obesity in Children, and End-Stage Renal Disease (ESRD). Dr. Harris is currently accepting new patients.

View All Doctors
What are the latest Hypomelanotic Disorder Clinical Trials?
A Phase 2, Randomized, 24-Week, Multicenter, Double-Blind, Placebo-Controlled Proof-of-Concept Study to Investigate Efficacy and Safety of LY4005130 in Adult Participants With Non-Segmental Vitiligo
A Phase 2, Randomized, 24-Week, Multicenter, Double-Blind, Placebo-Controlled Proof-of-Concept Study to Investigate Efficacy and Safety of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Enrollment Status: Recruiting
Publish Date: September 08, 2026
Intervention Type: Drug
Study Phase: Phase 2

Summary: The purpose of this study is to evaluate how well LY4005130 is tolerated and what side effects may occur in participants with non-segmental vitiligo (NSV) when compared with placebo. The study drug will be administered intravenously (IV) (into a vein in the arm). Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. The study wi...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Efficacy and Safety of Ruxolitinib Phosphate Cream Combined With Corticosteroids in Patients With Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Efficacy and Safety of Ruxolitinib Phosphate Cream Combined With Corticosteroids in Patients With Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Enrollment Status: Recruiting
Publish Date: September 08, 2026
Intervention Type: Drug

Summary: This study is a prospective, multicenter, real-world observational study to assess the clinical efficacy and safety of topical 1.5% Ruxolitinib phosphate cream used in combination with systemic corticosteroids in a real-world clinical setting. The study plans to observe patients aged 12 years and older with active, progressive non-segmental vitiligo involving the face. All treatments are prescribe...

View All Clinical Trials